RION (6823) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 of FY2026, revenue increased, but core operating profit remained at approximately the previous year's level. The earnings structure absorbed a decline in gross margin through reductions in SG&A expenses. Revenue was ¥205.5B (¥204.9B in the same period of the previous year, YoY +0.3%), operating income was ¥30.6B (¥30.7B, YoY -0.1%), ordinary income was ¥31.3B (¥31.3B, YoY +0.0%), and net income attributable to owners of the parent was ¥22.5B (¥21.3B, YoY +5.6%). The increase in net income was attributable to a reduction in extraordinary losses (¥1.3B in the previous year → ¥0.4B in the current period) and stable tax expenses, and was not accompanied by an improvement in the operating margin.

Factors Affecting Performance

【Revenue】Revenue was ¥205.5B, a modest increase of +0.3% year on year. By segment, Medical Equipment generated ¥94.2B (profit margin 10.7%), while Environmental Equipment generated ¥41.4B (profit margin 8.6%), with the medical equipment field accounting for the core of revenue. Progress against the full-year company forecast of ¥289.0B was 71.1%, slightly below the standard progress rate of 75%, making accelerated growth in Q4 a key challenge.

【Profit and Loss】The gross margin was 50.0%, down approximately 1.3pt from 51.3% in the same period of the previous year, and the increase in the cost-of-sales ratio weighed on operating income. Meanwhile, SG&A expenses decreased 3.0% year on year to ¥72.1B, and the SG&A ratio improved to 35.1% from 36.3% in the previous year, offsetting most of the deterioration in the gross margin. As a result, the operating margin was 14.9%, slightly down from 15.0% in the previous year, while ordinary income remained at the same level as the previous year. Net income increased due to the reduction in extraordinary losses. Overall, the results have a strong character of increased revenue but decreased profit (on an operating income and ordinary income basis), while net income reflects both increased revenue and increased profit.

Segment Analysis

Medical Equipment is the core business, with revenue of ¥94.2B and operating income of ¥10.0B (profit margin 10.7%), accounting for 45.8% of total company revenue. Environmental Equipment generated revenue of ¥41.4B and operating income of ¥3.5B (profit margin 8.6%), with a lower profit margin than the medical equipment segment. The two segments combined generated revenue of ¥135.6B and operating income of ¥13.5B. The difference from total company revenue of ¥205.5B is considered attributable to undisclosed other businesses and adjustments. The relatively high profit margin of the medical equipment segment supports the profitability of the company as a whole.

Key Financial Indicators

【Profitability】The operating margin of 14.9% and net profit margin of 10.9% were both at high levels. Compared with the same period of the previous year (15.0% and 10.4%), the operating margin declined slightly, while the net profit margin improved.【Cash Flow Quality】Comprehensive income was ¥25.6B, ¥3.1B higher than net income of ¥22.5B, primarily due to an increase in the valuation difference on other securities. This is a factor separate from the cash-generating power of the underlying business.【Investment Efficiency】Annualized ROE was 9.1%, total asset turnover was 0.692x, and financial leverage was 1.20x, indicating a conservative structure. The potential to improve asset efficiency represents the primary opportunity for increasing ROE.【Financial Soundness】The equity ratio was 83.6% (80.3% in the previous year), while cash and deposits were ¥78.6B (¥60.1B in the previous year, +30.6%). Both liquidity and the capital base were strong, and dependence on debt was extremely low.

Cash Flow Analysis

Although individual data from the cash flow statement have not been disclosed, fund movements can be inferred from changes in the balance sheet. Cash and deposits increased by ¥18.4B (+30.6%) to ¥78.6B from ¥60.1B in the same period of the previous year. Inventories were ¥84.6B, showing an increasing trend from ¥80.3B in the previous year, indicating that funds remain tied up in working capital. Current liabilities were ¥42.7B, down from ¥54.5B in the previous year, mainly due to reductions in accrued bonuses and accrued corporate taxes and other liabilities. Overall, although cash has accumulated, the high inventory level remains a point of caution from a capital efficiency perspective.

Quality of Earnings

Ordinary income was ¥31.3B, approximately unchanged from the same period of the previous year. Non-operating income of ¥1.1B (including dividend income of ¥0.4B, interest income, etc.) was limited to approximately 0.5% of revenue and did not materially supplement core earnings. Extraordinary losses were ¥0.4B, mainly consisting of losses on disposal of fixed assets, down from ¥1.3B in the same period of the previous year. This reduction contributed to the increase in net income (+5.6% year on year). The effective tax rate was approximately 27.2%, within a stable range. Comprehensive income of ¥25.6B exceeded net income of ¥22.5B and included increases in the valuation difference on other securities and foreign currency translation adjustments. Accordingly, it should be distinguished from the profitability of business activities themselves. Overall, the increase in profit for the current period included the temporary factor of reduced extraordinary losses and cannot necessarily be characterized as an expansion of recurring earnings power.

Earnings Forecast and Guidance

The full-year company forecasts are revenue of ¥289.0B (YoY +3.7%), operating income of ¥44.0B (YoY +9.1%), and ordinary income of ¥44.0B (YoY +7.1%). The Q3 cumulative progress rates were 71.1% for revenue and 69.7% for operating income, both below the standard progress rate of 75%. Net income progress was 71.4% (against the full-year forecast of ¥31.5B), slightly above operating income progress, but includes the impact of reduced extraordinary losses. To achieve the full-year operating income target, operating income of approximately ¥13.4B in Q4 and an operating margin of approximately 16% relative to revenue will be required, exceeding the cumulative operating margin of 14.9% for the current period.

Shareholder Returns

The Q2 dividend was ¥35.00 per share, resulting in a payout ratio of 19.2% against Q3 cumulative net income attributable to owners of the parent of ¥22.5B. Based on the full-year company forecast of a dividend of ¥85.00 and full-year net income of ¥31.5B, the forecast payout ratio is approximately 33.3%. The forecast payout ratio is below 60% and remains conservative even compared with the financial base, including cash and deposits of ¥78.6B and an equity ratio of 83.6%. Treasury shares are immaterial, and no increase in the total return ratio through large-scale share repurchases has been identified.

Risk Factors

1. Inventory and Working Capital Efficiency: Inventories were ¥84.6B, accounting for 21.4% of total assets. Prolonged inventory turnover days and the cash conversion cycle could increase the risk of inventory write-downs in the event of fluctuations in demand and reduce capital efficiency.

2. Structural Decline in Gross Margin: The gross margin declined approximately 1.3pt year on year to 50.0%. Although the impact on the operating margin was limited to -0.1pt through reductions in SG&A expenses (-3.0% year on year), there is a limit to the scope for cost reductions if higher costs and price competition continue.

3. Delayed Progress Toward Achieving the Full-Year Plan: The operating income progress rate of 69.7% was below the standard progress rate of 75%, requiring an operating margin of approximately 16% in Q4. Trends in demand at the end of the fiscal year and cost management will be key to achieving the plan.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net profit margin substantially exceeded the industry median, placing profitability among the top tier within the industry.

Growth and Capital Efficiency

The revenue growth rate was below the industry median, positioning the company unfavorably within the industry in terms of top-line growth.

※Source: Compiled by the Company

Key Points from the Earnings Results

1. The operating margin of 14.9% and net profit margin of 10.9% remain substantially above the industry medians (8.6% and 6.4%), demonstrating high profitability. However, if the downward trend in the gross margin continues, maintaining margins solely through SG&A controls may become increasingly difficult.

2. The company has an extremely conservative financial structure, with an equity ratio of 83.6% and a debt-to-equity ratio of 0.20x, providing high resilience to economic and demand fluctuations. Meanwhile, the low total asset turnover of 0.692x is observed as a structural factor constraining ROE of 9.1%.

3. Progress against the full-year forecast was below the standard level for both revenue and operating income, making the extent of recovery in Q4 revenue and profit margins the decisive factor in achieving the full-year plan.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,646–¥2,800 at ±1% in the cost of equity, and ¥2,720–¥2,723 at ±0.1 in ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing gap relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual income model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---